Analysis of clinical biopsies revealed that activated NF-κB colocalizes with IL-8 in the H. pylori-infected mucosa of patients with gastritis [9], making the chemokine and NF-κB signaling key targets in the search for new therapies to treat H. pylori-induced gastritis and ulcers in humans. This evidence concerns the gene NFKB1 and ulcer disease.